SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012034
Filing Date
2022-08-04
Accepted
2022-08-04 07:01:48
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220630x10q.htm   iXBRL 10-Q 1692967
2 EX-31.1 tmb-20220630xex31d1.htm EX-31.1 7126
3 EX-31.2 tmb-20220630xex31d2.htm EX-31.2 7116
4 EX-32.1 tmb-20220630xex32d1.htm EX-32.1 9203
5 GRAPHIC tmb-20220630x10q001.jpg GRAPHIC 17235
  Complete submission text file 0001558370-22-012034.txt   6032969

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20220630.xsd EX-101.SCH 40883
7 EX-101.CAL tmb-20220630_cal.xml EX-101.CAL 35312
8 EX-101.DEF tmb-20220630_def.xml EX-101.DEF 131861
9 EX-101.LAB tmb-20220630_lab.xml EX-101.LAB 332894
10 EX-101.PRE tmb-20220630_pre.xml EX-101.PRE 248074
56 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220630x10q_htm.xml XML 1072908
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37410 | Film No.: 221134579
SIC: 2834 Pharmaceutical Preparations